fda glp-1 compounding warning october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA warns against compounded GLP-1

Brain GLP 1 receptors directly influence hunger and food seeking behavior

The Healthy Weight Loss module is designed specifically for patients with clinical obesity (Rubino et al., 2023) who are motivated to pursue healthy and sustainable weight loss

If youve been hearing more about peptide therapy lately, theres a good reason for it

Ct values generated from the qPCR were plotted to produce standard curves (supplementary data), which were then used to calculate the total telomere length in kb for all samples

If you do consume sugar, your body handles it more efficiently than before treatment, though this benefit comes from the medication's mechanismnot from avoiding sugar entirely